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To determine the incidence of anemia among pediatric critical care survivors and to determine whether it resolves within 6 months
of discharge. Design. A prospective observational study. Patients with anemia upon discharge from the pediatric critical care unit
(PCCU) underwent in hospital and post hospital discharge followup (4–6 months) for hemoglobin (Hb) levels. Setting. A medicalsurgical PCCU in a tertiary care center. Patients. Patients aged 28 days to 18 years who were treated in the PCCU for over 24 hours.
Measurements and Main Results. 94 (24%) out of 392 eligible patients were anemic at time of discharge. Patients with anemia were
older, median 8.0 yrs [(IQR 1.0–14.4) versus 3.2 yrs (IQR 0.65–9.9) (𝑃 < 0.001)], and had higher PeLOD [median 11 (IQR 10–12)
versus 1.5 (1–4) (𝑃 < 0.001)], and PRISM [median 5 (IQR 2–11) versus 3 (IQR 0–6) (𝑃 < 0.001)] scores. The Hb level normalized
in 32% of patients before discharge from hospital. Of the 28 patients who completed followup, all had normalization of their Hb in
the absence of medical intervention. Conclusions. Anemia is not common among patients discharged from the PCCU and recovers
spontaneously within 4–6 months.

1. Introduction
Anemia is a frequent occurrence in critically ill patients [1]
and red blood cell (RBC) transfusions are commonly administered [1–3]. However, adult and pediatric literature suggests
that RBC transfusions in the critically ill pose multiple risks
[4, 5] and are associated with worsened clinical outcomes
[4–7]. Conversely, restrictive transfusion practices with subnormal levels of hemoglobin (Hb) are well tolerated by the
critically ill [1, 2, 4] and are associated with improved patient
outcomes when compared to a liberal transfusion strategy
[8]. While this issue is largely unaddressed in the pediatric
population, the only randomized controlled trial in children

to date (TRIPICU trial) supports the use of a restrictive transfusion strategy in critically ill children [9].
We postulated that pediatricians would demonstrate a
conservative approach to the use of RBC transfusions which
would result in a high incidence and magnitude of anemia
among patients discharged from the pediatric critical care
unit (PCCU). This phenomenon has recently been described
in a population of adult intensive care survivors in whom the
prevalence of anemia increased to 80% [10]. There is no published data regarding the occurrence of anemia in children
after critical care discharge. The objective of this study was to
test the hypothesis that anemia is common among patients
discharged from the PCCU and to determine the duration of
this anemia.
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2. Materials and Methods
The study protocol was reviewed and approved by the University of Western Ontario Health Sciences Research Ethics
Board. Written informed consent for blood and data collection was obtained from each patient and/or their parent or
guardian.
A prospective observational study was conducted in two
stages between September 2009 and November 2010 in the
PCCU of a tertiary care, university-affiliated hospital.
The first stage of the study was to establish the prevalence
of anemia among patients at time of discharge from the
PCCU. Anemia was defined as a Hb level 2 standard deviations below the mean adjusted value for age and sex (Table 1)
[11]. Severe anemia was defined as Hb ≤ 7 g⋅dL−1 for patients
≤ 1 year of age and Hb ≤ 8 g⋅dL−1 for children ≥ 1 year of
age. All patients discharged from the PCCU during the study
period were screened for anemia. Inclusion Criteria. Patients 1
month–18 years of age, admitted to the PCCU for greater than
24 hours with documented HgB level on capillary, venous, or
arterial blood sample collected within 48 hours of discharge
from the PCCU were eligible for inclusion. Exclusion Criteria.
Patients with cyanotic heart disease, chronic lung disease,
chronic renal failure, preexisting chronic anemia, active
bleeding, and patients undergoing myeloablative therapies
were excluded from the study.
The demographic data (age and sex), diagnosis, admission pediatric risk of mortality (PRISM III) score [12] and
pediatric logistic organ dysfunction(PELOD) score [13] of
each study patient were recorded at PCCU admission. Laboratory data collected included Hb on discharge, mean corpuscular volume (MCV), and reticulocyte count.
The second stage of the study was to establish the rate
of resolution of the anemia, determined through in hospital
and post hospital followup. All patients with anemia upon
discharge from the PCCU who agreed to participate were
followed during the remainder of their hospital stay and Hb
levels, blood transfusions, and/or iron supplementation were
documented until they were discharged.
Patients with anemia on a blood sample drawn within
72 hours of discharge from hospital were eligible for a post
hospital followup. The patients were required to visit the hospital 4–6 months after discharge. At that visit, a blood sample
was drawn for laboratory measurement of Hb level, MCV,
reticulocyte count, and ferritin levels. The parents and/or
patients were interviewed by a research assistant to exclude
the use of medications or the onset of new illnesses that might
alter the body’s response to anemia. Patients were excluded
from the post hospital followup portion of the study if they
were from remote areas that made followup at our institution
impractical or if they received iron supplementation.

2.1. Statistical Analysis. Data were analyzed using SigmaStat
software, version 3.5 for Windows (Systat Software, Inc.,
Chicago, IL). Normally distributed continuous variables were
compared between two groups using the independent samples t-test, and the Mann-Whitney test was used for skewed
continuous outcomes. A one-way ANOVA was used to
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Table 1: Anemia as defined by hemoglobin (Hb) levels based on age
(11).
Age
<2 m
3–11 m
1–4 y
5–13 y
Females ≥ 14 years
Males ≥ 14 years

Hb (g⋅dL−1 )
<8.0
<9.0
<10.0
<11.0
<12.0
<13.0

compare differences in continuous variables for more than
two groups. Data are expressed as means (standard deviation,
SD) or when the data are skewed, as medians (25th–75th percentile). A 𝑃 value <0.05 was considered statistically significant.

3. Results
3.1. Demographics and Prevalence. The flow chart of the
study is presented in Figure 1. The patient demographics are
presented in Table 2. During the study period (September
2009–November 2010), 779 patients were admitted to the
PCCU (Figure 1). Three hundred and eighty seven patients
(49.5%) were not eligible to participate in the study (e.g.,
chronic lung disease, known anemia, admission < 24 hours,
age ≤ 28 days). Of the 392 patients eligible for the study, 94
(24%) patients had anemia upon discharge from the PCCU.
Fifteen (3.8%) had severe anemia.
3.2. Transfusion Details during the Study Period (in the
PCCU). During the study period, 74 of the study patients
(18.8%), with a median age of 2.3 yrs (IQR 0.64–13.5), received
109 packed red blood cell transfusions. The mean pretransfusion Hb was 7.3±1.1 g⋅dL−1 . Forty-one percent (45/109) of the
transfusions occurred below the Hb threshold of 7.0 g⋅dL−1
(Figure 2).
3.3. Recovery from Anemia (Followup)
3.3.1. In Hospital Followup. 62 of the 94 (66%) patients with
anemia upon discharge from the PCCU (Figure 1) participated in the followup until discharge from hospital. Thirty
two patients were excluded because of the following: missing
Hb levels (𝑛 = 19), discharge to a different hospital (𝑛 = 8),
refusal to participate in the study (𝑛 = 3), or receipt of blood
transfusions (𝑛 = 2) (Figure 1). The patient demographics are
presented in Table 3. All had a normal MCV on admission
and all experienced a drop in Hb during their PCCU
stay. Sixteen out of the 62 (26%) patients received RBC
transfusions during their stay in the PCCU. Nineteen (31%)
recovered to normal Hb levels (without transfusion) while
still in hospital after a median period of 16.5 days (IQR 11.0–
27.5) after discharge from the PCCU, showing a recovery rate
of 1.9 ± 0.74 g⋅dL−1 of Hb per week. These patients were
discharged from hospital after a median of 28 days (IQR 18–
51.5) compared to a median of 7 (IQR 4–11) days for patients
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Table 2: Patient demographics.

No.
Age (years)
Female (%)
PRISM
PELOD admission
PELOD max
Length of PCCU stay (days)
Discharge Hb (g/dL)

Total patients
779
1.45 (0.8–9.4)
367 (47%)
3 (0–7)
10 (0–11)
10 (1–11)
2 (1–4.3)
12.0 ± 3.0

Nonanemic
298
3.2 (0.65–9.9)
148 (50%)
3 (0–6)
2 (0–11)
2 (1–11)
1 (1–4)
11.7 ± 1.6

Anemic
94
8.0 (1.0–14.4)
49 (52%)
5 (2–11)
10 (0–11)
11 (10–12)
4 (1.4–11)
8.4 ± 1.6

𝑃 value∗
—
<0.001
—
<0.001
0.002
<0.001
<0.001
<0.001

Data are presented as median (25th–75th percentiles) or mean ± SD.
∗
Anemic versus nonanemic.

779 patients were admitted to the
PCCU during the study period

392 patients were eligible to
participate in the study

94 (24%) patients had anemia at
discharge from the PCCU

62 patients were followed until
discharge from hospital

28 patients were followed up 4–6 months
after discharge

387 (49.6%) patients were excluded
- Death—19
- Length of stay <24 hours—276
- Underlying disease—56
- <28 days of age—188
- Lack of Hb levels—122
- Other—6

32 patients were excluded
- Discharged to different hospital
- Refused to participate
- Missing Hb levels
- Received blood transfusion (𝑛 = 1)
19 patients resolved anemia by discharge
15 patients were excluded
- Out of region
- Refused to participate
- 1 patient did not show up

Patients (%)

Figure 1: Flow chart of the study.

40

in whom the anemia persisted at the time of discharge from
hospital (𝑃 = 0.003).

30

3.3.2. Post Hospital Followup. 43 patients had anemia upon
discharge from hospital. Twelve patients were out of region,
resulting in 31 patients that were eligible for the long-term
followup. Two (6%) refused participation in the study, resulting in 29 patients enrolled and 28 completing the study. All
patients were found to have a normal Hb level within 4 to
6 months. Ferritin levels (54 ± 29.1 𝜇g⋅L−1 ) and MCV were
also normal (84.5 ± 5.5 fL). None of the followup patients was
transfused or received iron supplementation after discharge
from hospital.

20

10

0

<5

5.1–6

6.1–7 7.1–8 8.1–9 9.1–10
Hemoglobin (g·dL−1 )

>10

Figure 2: Percentage of patients receiving transfusions at predefined
hemoglobin thresholds during study period.

4. Discussion
The results of this study did not support our main hypothesis.
The incidence of anemia among patients discharged from

4
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Table 3: Follow-up patient characteristics (𝑛 = 62).

Age (years)
Under 2 years
Sex (female)
Diagnosis 𝑁 (%)
Postoperative
Trauma
Respiratory failure
Sepsis
Others
Length of stay PCCU (days)
Length of stay hospital (days)
PRISM at admission
PELOD at admission
PELOD max
Hb at admission (g/dL)
Mean corpuscular volume at
admission (fL)
Hb at discharge from the PCCU (g/dL)
Hb at discharge from hospital (g/dL)

13.7 (4.4–16.4)
11 (18%)
23 (47%)
26 (42)
16 (26)
9 (14)
9 (15)
2 (2)
3.0 (2.0–9.0)
11.0 (5.5–26.0)
5.0 (2.0–7.5)
7.0 (1–11)
11.0 (1–14)
11.5 ± 1.8
84.1 ± 4.9
8.1 ± 1.8
10.6 ± 1.7

Data are presented as median (25th–75th percentile) or mean ± SD.

the PCCU (24%) was lower than we expected and it had
resolved in all followup participants within 6 months of
PCCU discharge.
The mean pretransfusion Hb level in our study group was
7.3±1.1 g⋅dL−1 and over 80% of these patients were transfused
at an Hb level ≤ 8 g⋅dL−1 (Figure 2). This is a lower threshold
Hb level than observed in our PCCU (8.2 ± 1.8 g⋅dL−1 data
not published) in the year 2000 and reported in other North
American centers (8.8 ± 2.6 g⋅dL−1 ) [14] in 2000 and is
consistent with the restrictive transfusion strategy currently
promoted in the literature [9]. Regardless, in our current
study only 24% of patients had anemia on discharge from
the PCCU. This contrasts sharply with the reported rates of
anemia in adult critical care survivors (50–77%) [10] and
lower still than the 80% rate reported more recently in adults,
suggesting that the incidence of anemia in adults has
increased following the implementation of a restrictive transfusion strategy [15].
In our study patients with anemia were older and, as
expected, more ill (higher PRISM and PELOD scores) compared to patients without anemia (Table 2). The association
between severity of illness in the critical care population
and anemia has been reported previously [1, 14, 16, 17]. We
expected that the smaller blood volumes of younger children
would make them particularly susceptible to anemia secondary to frequent blood sampling [16, 17] and that they
would be disproportionately represented among patients discharged from the PCCU with anemia. Our study demonstrates the opposite and may reflect different thresholds for
blood transfusion between infants and older children.
During critical illness, the erythropoietic response to
anemia is blunted by reduction in erythropoietin production

[18, 19] and bone marrow suppression by various inflammatory cytokines [20–22]. Little is known regarding the rate of
recovery of normal erythropoiesis following critical illness.
Some suggest that the effect of blunted erythropoiesis may be
prolonged because of the presence of inflammatory cytokines
during recovery [23]. Other authors suggest that erythropoietin can be restricted by iron deficiency [24] and patients
discharged from the PCCU may have depleted iron stores [18]
and/or suffer from functional iron deficiency [25]. The rate of
recovery of the anemia is important as anemia in general, and
iron deficiency in particular, are known to impair immunity
and increase infection risk [26], impair myocardial function
[27], increase risk of thrombosis [28], cause fatigue [29],
and alter behavioral and developmental function [30]. We
found that the anemia resolved in less than 4–6 months in
all patients that underwent post hospital followup (𝑛 = 28).
Furthermore, 19 out of 62 patients (31%) with anemia on
discharge from the PCCU recovered their Hb to normal levels
while still in hospital. Since patients with anemia on discharge
from the hospital were discharged significantly earlier than
patients in whom the anemia resolved, one may speculate
that most of the children may have shown resolution of their
anemia well before the 4–6 month follow-up time. To the
best of our knowledge, the rate of recovery of Hb in healthy
children (e.g., after blood donation) has not been established.
The rate of recovery in healthy adults is about 1.0 g⋅dL−1 per
week [10]. This is significantly longer than the rate observed in
our study (1.9 ± 0.74 g⋅dL−1 per week) among patients whose
Hb recovered prior to hospital discharge (𝑛 = 20). Since
Hb levels were not checked daily, this probably represents an
underestimation of rate of recovery. A similar study in adults
[23] showed a slower rate of recovery with anemia persisting
in 53% of patients beyond 6 months. The slow recovery rate
was attributed to chronic inflammation as the patients who
did not recover had higher inflammatory markers (Il-6 and
C-reactive protein).
Although the determination of the etiology of the anemia
was not within the scope of this study, the normal MCV
and red cell distribution width on discharge exclude iron
deficiency anemia [11] and the relatively fast resolution of
anemia in children who stayed longer on the medical ward
leads us to speculate that hemodilution may have played an
important role. The vasodilatory effect of most sedative and
analgesic drugs provided to children who required mechanical ventilation, the effect of positive pressure ventilation
on preload requirement [31], and inappropriate antidiuretic
hormone secretion may lead to hemodilution in the critically
ill child. Unfortunately, the fluid balance for the patients who
participated in the study was not available to support our
hypothesis.
This study is the first to examine the incidence and time
to resolution of anemia among children discharged from the
PCCU. However, there are several limitations to this study;
specifically the relatively small number of patients who
participated in the follow-up portion (𝑛 = 62) of the study,
the relatively large number of patients who were excluded
from the follow-up study, and the small number of infants. As
serial measurements of Hb were not done, it was not possible
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to determine the time point at which anemia resolved in all
patients. Generalizability of the study to other centers with a
different patient mix or illness severity (specifically those with
pediatric cardiac surgery patients) may be limited.

5. Conclusions
We have shown that anemia was not very common among
patients discharged from the PCCU in the era of a restrictive
transfusion strategy. It was more common in older children
and it self-resolved within 6 months. The rate of Hb improvement suggested a normal erythropoietic response. Further
studies are needed in a larger group of children, particularly
those in the younger age group and children with higher
PRISM scores. The contribution of hemodilution to the magnitude of anemia in the critically ill pediatric patient should
also be examined.
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